The early biomarker challenge in neurodegenerative disorders
Biomarkers sensitive to a longer, ‘compensated’ presymptomatic phase of neurodegeneration are needed for preventative therapy development
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019
|